Source: International Congress 2015 – Advances in asthma and allergy in animal models
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Helen Meyer-Martin (Mainz, Germany), Helen Meyer-Martin, Susanne A. Hahn, Hendrik Beckert, Joachim Maxeiner, Petra Scholtes, Christian Taube, Roland Buhl, Stephanie Korn, Christian Becker, Helmut Jonuleit, Andrea Tüttenberg, Sebastian Reuter. GARP reduces inflammation in a humanized mouse model of allergic airway disease. Eur Respir J 2015; 46: Suppl. 59, 2006

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 The immunomodulatory activity of protein S protects against allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Adjuvant-free mouse model of allergic asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 IL-13 in a mouse model of chemical-induced airway hyperresponsiveness Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 The effect of anti-IL-33 antibody and soluble ST2 in a murine model of allergic asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Pim1 kinase affects allergic asthma in a HDM-driven mice model Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 25-hydroxyvitamin D promotes the long-term effects of specific immunotherapy (SIT) in allergic airway inflammation in mice Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 LSC 2014 abstract - RORgamma t-specific RNAi decreases allergic airway inflammation and airway hyperresponsiveness in a mouse model of neutrophilic asthma Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Investigating the role of BAFF in murine models of allergic asthma Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014